Bronchial CancerRehabKBPNCT03684486
Rehabilitation by Effort for Patients With Advanced Bronchial Cancer
A study testing rehabilitation by effort in people with Bronchial Cancer and Malignant Mesothelioma, run by University Hospital, Toulouse at 1 site in France.
Trial summary
Bronchopulmonary cancers or mesothelioma are associated with effort deconditioning due to pathology (chronic inflammation) and also to treatments (surgery, radiotherapy, chemotherapy); it's considerably alters patients quality of life. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Bronchial Cancer, Malignant Mesothelioma
- What is being tested?
- rehabilitation by effort
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 19 participants
- Where
- 1 siteFrance
- Study dates
- 1 Feb 2012to 24 Jul 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- General condition according to World Health Organisation 0-1
- Age between 18 and 70 years old
- Non progressive patients according to RECIST criteria 1.1 after chemotherapy treatment whichever line of treatment
- Autonomous patient
- Voluntary written informed consent signed
- Patients with social security insurance
Who cannot join
- Bone metastasis with fracture risk
- Significant cardiovascular pathology
- Cardiac, vascular, rheumatologic or neurologic contraindication
- Patients living far 60 kms from Toulouse
- Patients under juridical protection guardianship, or tutelage measure
Trial locations and contacts
1 site in 1 country.
About this study
Bronchopulmonary cancers or mesothelioma are associated with effort deconditioning due to pathology (chronic inflammation) and also to treatments (surgery, radiotherapy, chemotherapy); it's considerably alters patients quality of life.
Investigators want to ensured the feasibility of rehabilitation by effort for these patients.
- Conditions
- Bronchial Cancer, Malignant Mesothelioma
- Being tested
- rehabilitation by effort
- Keywords
- bronchial cancer, rehabilitation
- Medical subject headings
- Carcinoma, Bronchogenic, Mesothelioma, Malignant
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
rehabilitation by effortBehavioural
| Study group | Role | What they receive |
|---|---|---|
| rehabilitation by effort | Experimental | 8 sessions of rehabilitation by effort in sports medicine Receives: Behavioral: rehabilitation by effort |
What is being measured
The primary outcome is the main question the study is designed to answer.
patients who completed at least 6 sessions of rehabilitation
number of patients who completed at least 6 sessions of rehabilitation by effort
Measured: 10 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2018
- Study start1 Feb 2012
- Primary completion24 Jul 2019
- Study completion24 Jul 2019
Why it stopped: recruitment difficulties
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bronchial CancerStudies of the same condition, open and under way.
- More trials run by University Hospital, ToulouseThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 19 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Toulouse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Julien Mazières, MD PhD, Principal investigator, University Hospital, Toulouse
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03684486
- Sponsor's protocol ID
- RC31/11/0087
- Acronym
- RehabKBP
- Status last verified
- Apr 2026
- First submitted
- 24 Sep 2018
- Last updated
- 6 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Rehabilitation by Effort for Patients With Advanced Bronchial Cancer
- ClinicalTrials.gov ID
- NCT03684486
- Acronym / sponsor ID
- RehabKBP / RC31/11/0087
- Conditions
- Bronchial Cancer, Malignant Mesothelioma
- Keywords
- bronchial cancer, rehabilitation
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: recruitment difficulties
- Enrolment
- 19 participants (actual)
- Lead sponsor
- University Hospital, ToulouseUniversity, hospital or other
- Study start
- 1 Feb 2012 (actual)
- Primary completion
- 24 Jul 2019 (actual)
- Study completion
- 24 Jul 2019 (actual)
- First posted
- 25 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Bronchopulmonary cancers or mesothelioma are associated with effort deconditioning due to pathology (chronic inflammation) and also to treatments (surgery, radiotherapy, chemotherapy); it's considerably alters patients quality of life.
Investigators want to ensured the feasibility of rehabilitation by effort for these patients.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| rehabilitation by effort | Experimental | Behavioral: rehabilitation by effort8 sessions of rehabilitation by effort in sports medicine |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- General condition according to World Health Organisation 0-1
- Age between 18 and 70 years old
- Non progressive patients according to RECIST criteria 1.1 after chemotherapy treatment whichever line of treatment
- Autonomous patient
- Voluntary written informed consent signed
Key exclusion criteria (5 listed)
- Bone metastasis with fracture risk
- Significant cardiovascular pathology
- Cardiac, vascular, rheumatologic or neurologic contraindication
- Patients living far 60 kms from Toulouse
- Patients under juridical protection guardianship, or tutelage measure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| rehabilitation by effort | Behavioural | rehabilitation by effort |
Primary outcome
patients who completed at least 6 sessions of rehabilitation
Time frame: 10 years
number of patients who completed at least 6 sessions of rehabilitation by effort
Results and safety
The study was stopped early (reason given: recruitment difficulties). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2026.
Related trials for Bronchial Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
A Prospective ,Multicenter ,Non-interventional ,Real-world Study Observing Changes in Molecular Markers Osimertinib Targeted Therapy in EGFRm NSCLC
Non Small Cell Lung Cancer
RecruitingPhase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Active, not recruitingPhase 2
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
Metastatic Lung Cancer, Advanced Non Small Cell Lung Cancer
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Julien Mazières, MD PhD principal investigator
University Hospital, Toulouse
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing rehabilitation by effort in people with Bronchial Cancer and Malignant Mesothelioma, run by University Hospital, Toulouse at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: recruitment difficulties). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
patients who completed at least 6 sessions of rehabilitation (time frame: 10 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.